Raid Aljumaily to Organoplatinum Compounds
This is a "connection" page, showing publications Raid Aljumaily has written about Organoplatinum Compounds.
Connection Strength
0.196
-
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial. Lancet Oncol. 2018 01; 19(1):51-64.
Score: 0.150
-
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2021 02; 39(1):182-192.
Score: 0.045